These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 29323718

  • 1. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
    Huang Y, Fan X, Tao R, Song Q, Wang L, Zhang H, Kong H, Huang J.
    J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
    [Abstract] [Full Text] [Related]

  • 2. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
    Fu J, Wu B, Zhong S, Deng W, Lin F.
    Biochem Biophys Res Commun; 2020 Sep 03; 529(4):922-929. PubMed ID: 32819600
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H, Zhu J, Hu C, Song H, Li Y.
    J Physiol Biochem; 2016 Dec 03; 72(4):721-732. PubMed ID: 27534652
    [Abstract] [Full Text] [Related]

  • 4. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q, Yang X, Zhou X, Wu B, Zhu D, Jia W, Chu J, Wang J, Wu J, Kong L.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):889-897. PubMed ID: 32279994
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK.
    Oncotarget; 2015 Jun 20; 6(17):15035-49. PubMed ID: 25909227
    [Abstract] [Full Text] [Related]

  • 6. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
    Lian R, Lu B, Jiao L, Li S, Wang H, Miao W, Yu W.
    Eur J Pharmacol; 2016 Dec 05; 792():1-6. PubMed ID: 27751825
    [Abstract] [Full Text] [Related]

  • 7. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK, Ma T, Yu Y, Suo Y, Li K, Song SC, Zhang W.
    Technol Cancer Res Treat; 2019 Dec 05; 18():1533033819886897. PubMed ID: 31714185
    [Abstract] [Full Text] [Related]

  • 8. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 05; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 05; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y, Wang LQ, Guo QY, Shi TL.
    Int J Clin Exp Pathol; 2015 Dec 05; 8(3):2461-72. PubMed ID: 26045752
    [Abstract] [Full Text] [Related]

  • 11. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H, Fang R, Li Y, Li L, Zhang W, Wang H, Chen F, Zhang S, Zhang X, Ye L.
    Cancer Lett; 2016 Nov 28; 382(2):147-156. PubMed ID: 27609066
    [Abstract] [Full Text] [Related]

  • 12. MiR-320a was highly expressed in postmenopausal osteoporosis and acts as a negative regulator in MC3T3E1 cells by reducing MAP9 and inhibiting PI3K/AKT signaling pathway.
    Kong Y, Nie ZK, Li F, Guo HM, Yang XL, Ding SF.
    Exp Mol Pathol; 2019 Oct 28; 110():104282. PubMed ID: 31301305
    [Abstract] [Full Text] [Related]

  • 13. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
    Li X, Li H, Zhang S, Zhang R, Li J, Wei Y, Yang C, Zhang F, Zhou H.
    J Cell Mol Med; 2021 Dec 28; 25(24):11185-11197. PubMed ID: 34747105
    [Abstract] [Full Text] [Related]

  • 14. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Dec 28; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 15. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B, Wen S, Li Y, Bai F, Wei Y, Xiong Y, Huang Q, Lin X.
    Int Immunopharmacol; 2021 Mar 28; 92():107208. PubMed ID: 33444919
    [Abstract] [Full Text] [Related]

  • 16. miR-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN/PI3K/AKT pathway.
    Hao XJ, Xu CZ, Wang JT, Li XJ, Wang MM, Gu YH, Liang ZG.
    J Recept Signal Transduct Res; 2018 Mar 28; 38(5-6):455-461. PubMed ID: 31038023
    [Abstract] [Full Text] [Related]

  • 17. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM, Li TH, Yun H, Ai HW, Zhang KH.
    Yonsei Med J; 2019 Jun 28; 60(6):561-569. PubMed ID: 31124340
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM, Luo Y, Li DF, Wei CK, Hua KY, Song JL, Xu H, Maskey N, Fang L.
    Int J Clin Exp Pathol; 2015 Jun 28; 8(9):9889-900. PubMed ID: 26617698
    [Abstract] [Full Text] [Related]

  • 19. Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner.
    Liu P, Wang M, Lu XD, Zhang SJ, Tang WX.
    World J Gastroenterol; 2013 Feb 28; 19(8):1230-8. PubMed ID: 23482848
    [Abstract] [Full Text] [Related]

  • 20. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.
    Gene; 2017 Jan 05; 596():110-118. PubMed ID: 27746366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.